July 21, 2019


Immunotherapy for Prostate Cancer-Hope Medical Group


Disadvantages of Radiotherapy & Chemotherapy
Chemotherapy works by interrupting cell division in cells that are multiplying quickly. Since cancer cells reproduce at an abnormally fast rate, they are affected by chemotherapy. Several cycles are needed to catch more cells, since not all of them will be dividing on the day you get chemotherapy. Unfortunately, other cells in your body also reproduce quickly enough to be affected by the treatment. Hair follicles shut down, which means your hair either falls out or does not grow. The linings of the mouth, stomach, and intestines also contain cells that multiply rapidly. These cells are disrupted by chemotherapy, which can cause mouth sores, a "burned tongue" sensation, nausea, constipation, hemorrhoids, and diarrhea.
The disadvantage of radiotherapy is also the worry that the cancer will come back.

Non-surgical treatments
DC + CIK cells can effectively cure cancer.
Today, tumors can be detected early and removed with advanced surgery and treatment, but current therapies cannot prevent or eradicate cancer after metastatic spread to distant organs. The prognosis is very poor if Cancer spreads to the brain. As a shielded "sanctuary site," the brain may harbor cancer cells which resist current treatments and can develop into satellite tumors, known as metastases, long after chemo-, radiation, or immuno- therapies have been applied. The patient's situation can be managed in the clinic only for a few weeks or months before becoming fatal.
Our DC+CIK cancer treatment provides new hope for patients, through an innovative approach based on stem cells, the body's own natural mechanism for healing and regeneration.
Cytokine-induced killer (CIK) cells are important immune cells, and dendritic cells (DC) can be induced to be co-cultured with CD3 + CD56 + (NKT) phenotype main groups of T-killer cells (DCCIK). Immunotherapy in cancer patients showed a broad spectrum of killing tumor cells, its function and use of exogenous split-mediated tumor cell material, tumor-associated antigen-activated DC, CIK cells co-cultured cells different, is not major histocompatibility complex (MHC) restricted, and there is a strong anti-tumor immune activity. It also significantly reduces the immune tolerance of cancer patients, a decrease of T suppressor cells (Treg1 immunosuppression and effectively prevent the generation of autoimmune disease in patients.

In short, DC+CIK cells in the human body's own immune system enhance and rebuild its immune system, automatically identify and track tumor cells, and transmit this information to patients own immune cells, promoting their activation and proliferate to eliminate residual metastatic lesions, prevent spread and recurrence of cancer and enhance immunity. This improves the quality of life of patients, ultimately prolonging the patients life for years.

 Every man over 40 get a blood test called Prostate Specific Antigen to check for prostate cancer, prostate Specific Antigen is made by prostate cells and is released into the bloodstream. Large prostates have more PSA, so a rise in PSA means that the gland is enlarging rapidly, which can be a sign of cancer or that the prostate is irritated by infection. Any manipulation of the prostate raises blood PSA levels. PSA levels can be raised for several hours just by having your prostate checked by a physician (2,3), so PSA blood tests should be drawn before the doctor examines the prostate. Having a climax raises PSA for up to 48 hours (5,6,7,8,9,10,11,12). Infections raise PSA and there is no way to tell the difference between a PSA raised by cancer or by infection.

PSA can be classified into two different fractions called free and bound PSA. Free PSA is made by a normal prostate, while bound PSA is made primarily by prostate cancer cells. The usual rule is that if a man's PSA is above 4 (normal 0-4), the free PSA should be at least 18 percent of the total PSA. This rule usually holds for every situation except infection. The ratio of free PSA to bound PSA is the same for prostate cancer and infections.

PSA aka Prostate Specific Antigen is a protein enzyme produced in the prostate gland and released in to the blood stream thereafter. After a blood work analysis, the resulting PSA test score shows how much of this enzyme you're producing, and your probability of having prostate cancer.

Normal PSA Scores
- 15% of men with psa levels less than 4 ng/ml develop prostate cancer.
- 31% of men with prostate cancer screening between 4 - 10 ng/ml develop prostate cancer.
- 50% - 65% of men with psa scores over 10 ng/ml develop prostate cancer.
An important part of the your results is finding both the;
1. Total amount of PSA in your blood.
2. Ratio of free vs bound PSA.

 For more information on stem cell immunotherapy for prostate cancer, please complete a medical form here or visit http://hopestemcell.com/cancer-immunology


Free Medical Evaluation




International patients contact:


This email address is being protected from spambots. You need JavaScript enabled to view it.


Hospital Treatments